Neutrophil extracellular traps in children with meningococcal sepsis by Hoppenbrouwers T et al.
1 
 
Neutrophil extracellular traps in 
children with meningococcal sepsis 
Tamara Hoppenbrouwers, MSc*1,2, Navin P. Boeddha, MD*3,4, Ebru Ekinci4,Marieke Emonts, PhD5,6 
,Jan A. Hazelzet, Prof7 ,Gertjan J. Driessen, PhD**4,8 ,Moniek P. de Maat, PhD**2 
 
Running title: NETs in meningococcal sepsis  
 
1) Department of Plastic and Reconstructive Surgery, Erasmus University Medical Center, Rotterdam 
The Netherlands 
2) Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands 
3) Intensive Care and Department of Pediatric Surgery, Sophia Children’s Hospital, Erasmus 
University Medical Center, Rotterdam, The Netherlands 
4) Department of Pediatrics, Division of Pediatric Infectious Diseases & Immunology,  Sophia 
Children’s Hospital, Erasmus University Medical Center, Rotterdam, The Netherlands 
5) Paediatric Infectious Diseases and Immunology Department, Great North Children's Hospital, 
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom 
6) Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom 
7) Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands 
8) Department of Paediatrics, Juliana Children's Hospital/Haga Teaching Hospital, The Hague, The 
Netherlands 
 
* These authors have contributed equally to the work presented in this manuscript. 
** These authors have contributed equally to the work presented in this manuscript 
2 
 
 
Corresponding author: 
Dr. M.P.M. de Maat 
Dept Hematology, Nb845a 
Erasmus University Medical Center 
P.O. Box 2040 
3000 CA Rotterdam 
The Netherlands 
Tel. +31 10 703 34 42 
Email: m.demaat@erasmusmc.nl 
 
Conflict of Interest: 
The authors declare no conflict of interest. 
 
Financial support: 
Research leading to these results has received funding from the European Union’s seventh 
Framework program under EC-GA no. 279185 (EUCLIDS). Also, research has been supported, in part, 
by an unrestricted grant from Baxter Bioscience, Vienna, Austria, in 2000. These funders had no role 
in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 
 
 
3 
 
Abstract 
Objective 
Children with meningococcal sepsis are highly at risk for fulminant disease, multi-organ failure and 
death. Recently, neutrophil extracellular traps (NETs) levels have been indicated as a marker for 
severity in different kinds of sepsis. Our aim was to study the role of NETosis in meninogococcal 
sepsis in children.  
 
Design and setting 
We measured MPO-DNA, a marker for NETs, in serum of meningococcal sepsis patients upon 
admission to PICU, at 24 hours, and at 1 month and studied the association with clinical outcome. 
Subsequently, we tested whether N. meningitidis, isolated from children with meningococcal sepsis, 
were able to induce NETosis, using confocal microscopy live imaging. 
 
Patients 
We included exclusively children with meningococcal sepsis.  
 
Interventions 
From each patient, serum was collected for analysis.  
 
Measurements 
We used ELISAs to measure MPO-DNA in patients serum. We also included inflammatory markers 
that were previously measured in this group.  
  
Main results 
MPO-DNA levels at admission (n=35, median 0.21 AU/mL, IQR 0.12-0.27) and at 24 hours (n=39, 
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median 0.14 U/mL, IQR 0.09-0.25) were significantly higher than the MPO-DNA levels after 1 month 
(controls, n=36, median 0.07 AU/mL, IQR 0.05-0.09, p<0.001). We did not observe a correlation 
between MPO-DNA levels and mortality, cell-free DNA or other inflammatory markers. In addition, N. 
meningitidis are fast and strong inducers of NETosis. 
 
Conclusions 
Children admitted to PICU for meningococcal sepsis have higher NETs levels at admission and after 
24 hours than controls. NETs levels were not associated with outcome, cell-free DNA or other 
inflammatory markers. These NETs may be induced by N. meningitidis, since these are strong NETosis 
inducers. 
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Introduction 
Meningococcal sepsis is notorious for its rapid progression to fulminant disease, multi-organ failure 
and death 1, 2. Complex interplays between host, pathogen, and environmental factors, including 
immune evasion mechanisms, determine the severity of Neisseria meningitidis infections, ranging 
from harmless colonization to lethal disease 3-5. 
 
A recently identified mechanism that may play a role in the pathology of meningococcal sepsis is 
NETosis. The release of neutrophil extracellular traps (NETs) is an important part of innate immune 
defense 6, 7. NETs are an extracellular DNA matrix, containing also granule proteins and histones, 
released by neutrophils to degrade virulence factors and to kill bacteria 8. NETs are primarily 
considered as a protective mechanism against a broad range of microorganisms, including gram-
negative and gram-positive bacteria, because they prevent bacteria from spreading and contain toxic 
histones 8, 9. Several inducers of NETosis are known, including bacterial species such as 
Staphylococcus aureus 10. Multiple studies describe a negative influence on outcome in mice and 
humans 11, 12, since the tissue damage caused by NETs may contribute to disease severity 13, 14. Also 
cell free DNA (cfDNA), the backbone of a NET, has been described to contribute to disease via the 
formation of microthrombi and to inhibit fibrinolysis 15. 
 
Studies on the relationship between NETs and Neisseria meningitidis in sepsis are lacking. Our 
objective was to study the role of NETs in children with meningococcal sepsis. We measured levels of 
NETs, cell-free DNA and other inflammatory markers in serum from children with meningococcal 
sepsis and studied the association with severity of disease. We also investigated whether N. 
meningitidis isolates from patients are able to induce NETosis.   
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Material and methods 
Patients and samples 
From 1988 to 2005, children with meningococcal sepsis presenting to the pediatric intensive care 
unit (PICU) of Erasmus MC-Sophia Children’s Hospital (Rotterdam, The Netherlands) were 
prospectively enrolled in meningococcal studies 16-19. These studies were conducted in accordance 
with the Declaration of Helsinki and Good Clinical Practice guidelines. All individual meningococcal 
studies as well as the current laboratory study (MEC-2015-497) were approved by the ethical 
committee of Erasmus MC, and written informed consent was obtained from parents or legal 
guardians. All patients fulfilled internationally agreed criteria for sepsis 20. Blood samples were taken 
on admission to PICU, at 24 hours after PICU admission, and at 1 month after PICU admission. Since 
all children were healthy at 1 month, the 1 month convalescence samples were used as controls. 
Samples were processed on ice and serum was stored at -80°C until analysis. This is a retrospective 
laboratory study in remaining samples of prospectively collected samples. 
 
Clinical data collection 
Clinical data were collected prospectively. Disease severity was indicated by Pediatric Risk of 
Mortality (PRISM) 21, predicted death based on the Rotterdam score 17, disseminated intravascular 
coagulation (DIC) score 22, and the base excess and platelet count at presentation (BEP) score 23. 
Patients were classified as death if death occurred during PICU-stay. PICU-free days in patients who 
died were considered zero.  
 
 
NETosis measurements  
Our MPO-DNA ELISA assay was performed as reported earlier 24. For detection of NETs in serum, we 
adjusted the commercial human ELISA kit that measures cell death (Cell death detection ELISAPLUS, 
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Cat. No 11920685001, Roche Diagnostics Nederland B.V., Almere, the Netherlands) 25. Briefly, ELISA 
plates were coated with a mouse-anti-human myeloperoxidase (MPO) monoclonal antibody (AbD 
Serotec, Oxford, UK), a NETs marker, overnight at 4 °C. The plates were then washed with Phosphate 
Buffered Saline (PBS) containing 0,05 % v/v Tween®-20 and incubated with blocking solution (1% 
BSA/PBS) overnight at 4 °C. Next, samples were added to the plate and incubated with MPO-DNA 
immunoreagens for 2 hours at 300 rpm at RT, washed and incubated with 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS) reagens for 30 min at 250 rpm at RT. The reaction was 
stopped with stop solution from the kit and plates were measured using a Biotek reader (FLX 800, 
Austria) at 405 nm with a 490 nm reference filter. The NETs reference curve was created from 
neutrophils that were transferred to FBS serum and stimulated with phorbol-myristate-acetate 
(PMA) for 4 hours. Samples were serially diluted and stored at -80°C. Values are expressed as 
arbitrary units (AU/mL).  
Inflammatory markers CRP, fibrinogen, soluble TNFr, IL-1B, IL-6, and IL-8 and cell-free DNA 
(nucleosomes) were measured in previous studies from our research group 16-19, 26. 
 
Neutrophil isolation 
Neutrophils were isolated as previously described 10. Briefly, red blood cells and granulocytes were 
isolated from blood from adult healthy donors, as approved by the Medical Ethics Committee of the 
Erasmus MC, using LymphoprepTM (Stem cell Technologies, Grenoble, France). Granulocytes were 
further purified by lysing the erythrocytes with erythrolysis buffer (3.1M NH4Cl, 0.2M KHCO3, 0.02M 
EDTA, pH 7.4) and washing the neutrophil rich pellet twice with HEPES (0.115M NaCl, 0.012mM 
CaCl2, 1.51mM MgCl2, 4mM KCl, 0.01M HEPES, pH 7.4) buffer.  
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In vitro NETosis  
For experiments with meningococcal bacteria, neutrophils were transferred to Dulbecco’s Modified 
Eagle Medium (DMEM) culture medium without any additions (Biowhittaker, Lonza, Walkersville, 
USA) in a confocal ring. Propidium Iodide (PI, 1:400, Sigma Aldrich, Zwijndrecht, The Netherlands) 
was added to visualize extracellular DNA during live imaging.    
 
To visualize extracellular DNA (NETs), neutrophils were stained for DNA with Hoechst 34580 (1: 
10000, Life Technologies, Landsmeer, The Netherlands) and PI (1:400, Sigma Aldrich, Zwijndrecht, 
The Netherlands) prior to contact with N. meningitidis as described previously by our group 27. 
Clinical isolates of N. meningitidis bacteria were cultured as described previously 28. After 4 hours of 
culturing, 100 µl 1x108/ml bacteria were added to 500 µl 2x106/ml neutrophils. NETs were visualized 
using confocal microscopy (Leica SP5 AOBS). Excitation of Hoechst with a 405 laser and a BP 420-500 
emission filer, and excitation of PI with a 561 141 and BP 580-620 emission filter. Elongated PI 
positive structures larger than 10 µm (the average diameter of a neutrophil) were defined as NETs. 
Round PI positive structures equal or smaller than 10 µm were defined as necrotic neutrophils.      
 
Statistical analysis 
Patient characteristics and MPO levels are presented as numbers and proportions (means and 
percentages) or medians and interquartile ranges. To compare MPO-DNA levels between the three 
time points, we used the Kruskal-Wallis test, including the post-hoc Mann-Whitney rank-sum test. To 
compare MPO-DNA level between survivors and non-survivors, we used the Mann-Whitney rank-
sum test. Correlations were assessed using Spearman’s rank correlation. Linear regression analyses 
were performed on logarithmically transformed data. Graphs were created with GraphPad Prism 
7.00. All statistical analyses were performed using Statistical Package for the Social Sciences (SPSS, 
IBM, version 21). Two-sided p-values <0.05 were considered to indicate statistical significance. 
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Results 
NETs levels in meningococcal sepsis 
In this study we included 60 children with meningococcal sepsis (58% male, median age 2 years and 
10 months [IQR 21 months-9 years]), of whom 35, 39, and 36 serum samples were available 
originating from admission to PICU, after 24 hours, and at 1 month, respectively. Patient 
characteristics are presented in Table 1. 
 
MPO-DNA levels at admission (n=35, median 0.21 AU/mL, IQR 0.12-0.27) and at 24 hours (n=39, 
median 0.14 AU/mL, IQR 0.09-0.25) were significantly higher than the convalescent MPO-DNA levels 
in the control group of survivors after 1 month (n=36, median 0.07 AU/mL, IQR 0.05-0.09, p<0.001) 
(Figure 2A). The MPO-DNA level in children who eventually died did not differ significantly from 
survivors at admission to PICU (non-survivors: n=11, median 0.23 AU/mL, IQR 0.12-0.47; survivors: 
n=23, median 0.16 AU/mL, IQR 0.12-0.25, p=0.14) and after 24 hours (non-survivors: n=3, median 
0.14 AU/mL; survivors: n=34, median 0.15 AU/mL, IQR 0.09-0.26, p=0.48) (Figure 2B). 
 
NETs and inflammatory markers in sepsis  
Since NETs can be induced by inflammatory markers, and NETs in turn can lead to an increased 
inflammatory response, we explored the correlations between inflammatory markers (neutrophil 
count, and serum C-reactive protein (CRP), fibrinogen, soluble Tumor Necrosis Factor (TNFr), 
Interleukine (IL)-1B, IL-6 and IL-8 levels) and MPO-DNA levels in our samples. We did not observe any 
significant correlation of NETs levels with any of these markers (Table 2).  
NETs and cell-free DNA 
Because nucleosome levels in serum reflect cell-free DNA, we tested how serum levels of 
nucleosomes were correlated to serum levels of NETs. We did not find a significant correlation 
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between nucleosomes and MPO-DNA at any of the time points (t=0: r=0.162, p= 0.54; t=24: r=0.044, 
p=0.86; t=1m: r=0.025, p=0.93). 
In vitro formation of NETs in the presence of Neisseria meningitidis 
In our pilot experiment, we saw that clinical isolates from N. meningitidis induce NETs in vitro in adult 
neutrophils. NETs were visible after 15 minutes of incubation of neutrophils with the bacteria (Fig. 1). 
In the control experiment with unstimulated neutrophils without bacteria, no NETs were seen. 
 
Since neutrophils started dying approximately 30-40 minutes after contact with N. meningitidis, we 
only observed NETs within this time frame.  
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Discussion  
This is the first study to describe NETs in children with meningococcal sepsis, describing both in vitro 
and in vivo data. The main findings of our study arethat NETs levels in these children are higher at 
admission to PICU and after 24 hours compared to levels after one month. We also found that NETs 
levels were not associated with clinical outcome in our cohort. Lastly, in a pilot experiment we found 
that N. meningitidis, isolated from children with meningococcal sepsis, are strong NETs inducers in 
adult neutrophils. 
 
In our study the NETs levels, measured by MPO-DNA levels, in children with meningococcal sepsis are 
higher in the acute phase of disease, i.e. at admission to PICU and at 24 hours after admission, 
compared to 1 month. Similar results were previously observed in adult studies, reporting increased 
NETs levels during the acute phase of sepsis 11, 13, 29. 
 
Multiple animal and patient studies associated NETs levels with sepsis severity and outcome 13, 14. 
This effect of NETs in sepsis likely results from the interplay between NETs, platelets and thrombin, 
which activates coagulation and inhibits fibrinolysis, leading to more severe DIC 13, 14, 30. In our study, 
we did not find an association between NETs, severity parameters, and outcome. Our study group 
was relatively small, and may have been underpowered to detect these effect. Alternatively, the 
positive and negative effects of NETosis, respectively containing meningococcal infection and 
inducing tissue damage and deregulate coagulation might be balanced in meningococcal sepsis in 
children.  
 
Previously, Zeerleder et al (2013) 31 measured nucleosomes in this cohort and reported that 
nucleosomes are correlated with several factors, such as organ dysfunction, several cytokines and 
patient outcome. In some studies, nucleosomes are used as marker for NETosis 32. We did not 
observe a correlation between MPO-DNA and nucleosome levels in this study, indicating that the 
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nucleosomes in these patients are probably cell-free DNA originating of other cell death mechanisms 
than neutrophils in NETosis. In sepsis patients, severe tissue and organ damage are the main cause of 
death. Cell-free DNA is therefore very likely originating from these damaged cells.  
 
We have shown in a pilot experiment that N. meningitidis isolated from sepsis patients, are able to 
induce NETosis in neutrophils in vitro. This is in line with a previous study on NETs formation by N. 
meningitidis 28. This article describes that N. meningitidis is also able to evade NETs different from S. 
aureus, which excretes nucleases to break down the NETs 33. N. meningitidis secretes small outer 
membrane vesicles (SOMVs) that bind to the NETs, blocking the binding of the bacteria themselves. 
In our experiments, we observed that after 30-40 minutes, neutrophils underwent necrosis next to 
NETosis, as expected since the bacteria are known to be toxic. Altogether, our results indicate that N. 
meningitidis has developed multiple mechanisms to avoid and destroy neutrophils, which might 
contribute to the severe pathogenesis of these bacteria in sepsis.  
 
This is the largest prospective cohort of children with severe meningococcal disease of which 
detailed clinical and extensive laboratory data are available. Although a total number of 60 patients 
might be relatively small compared to adult sepsis cohorts, the advantage from our study is that 
these children are all affected by the same bacterium, N. meningitidis. The detailed assays performed 
and measurements of several factors over time allowed us to study correlations with markers 
assessed in both the current and previous studies 26, 31. Also, we were able to follow these patients 
over time and collect data on many variables, including NETs and inflammatory markers. 
 
We have shown that N. meningitidis is capable of inducing NETosis in neutrophils isolated from 
healthy adult donors in vitro. Unfortunately age matched donors were not available, as volumes 
obtained for diagnostic tests are limited in children. Therefore we cannot exclude that neutrophils of 
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children might react differently 34. However, as NETs were present in our patient serum samples, 
such a difference in vitro is not expected. 
Conclusions 
N. meningitidis are strong NETs inducers. Children admitted to PICU for meningococcal sepsis have 
higher NETs levels at admission and after 24 hours than controls. NETs levels were not associated 
with positive or negative outcome or other inflammatory markers, indicating that the beneficial and 
detrimental effects of NETosis in meningococcal sepsis might be balanced. We also did not find a 
correlation between MPO-DNA and nucleosomes, indicating that nucleosomes are not only NETs but 
all cell free DNA.  
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Figure legends 
 
Figure 1: Unstimulated neutrophils (A) vs NETs (see arrows) formed by N. meningitidis (B). Blue: 
Hoechst staining for DNA. Red: PI staining for extracellular DNA (NETs) and dead cells.  
 
Figure 2: MPO-DNA levels measured at different time points (A) and in relation to survival (B).  
 
